Literature DB >> 16103210

Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization.

Rik L de Swart1, Selma Yüksel, Albert D M E Osterhaus.   

Abstract

The relative contribution of measles virus hemagglutinin (H)- or fusion protein (F)-specific antibodies to virus neutralization (VN) has not been demonstrated. We have depleted these specific antibodies from sera collected from young adults, who had been vaccinated during childhood, by prolonged incubation with viable transfected human melanoma cells expressing H or F. Simultaneous depletion of antibodies of both specificities completely abrogated VN activity. Depletion of F-specific antibodies only had a minimal effect, whereas removal of H-specific antibodies resulted in almost complete reduction of VN activity. These results demonstrate that measles virus neutralizing antibodies are mainly directed to the H protein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103210      PMCID: PMC1193617          DOI: 10.1128/JVI.79.17.11547-11551.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

Review 1.  Neutralizing B cell response in measles.

Authors:  Fabienne B Bouche; Oliver T Ertl; Claude P Muller
Journal:  Viral Immunol       Date:  2002       Impact factor: 2.257

2.  Resistance of recent measles virus wild-type isolates to antibody-mediated neutralization by vaccinees with antibody.

Authors:  M Klingele; H K Hartter; F Adu; W Ammerlaan; W Ikusika; C P Muller
Journal:  J Med Virol       Date:  2000-09       Impact factor: 2.327

3.  Update of the nomenclature for describing the genetic characteristics of wild-type measles viruses: new genotypes and reference strains.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2003-07-04

4.  Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies?

Authors:  Sabine Santibanez; Stefan Niewiesk; Alla Heider; Jürgen Schneider-Schaulies; Guy A M Berbers; Albert Zimmermann; Anne Halenius; Anne Wolbert; Ingrid Deitemeier; Annedore Tischer; Hartmut Hengel
Journal:  J Gen Virol       Date:  2005-02       Impact factor: 3.891

Review 5.  Measles: not just another viral exanthem.

Authors:  Trevor Duke; Charles S Mgone
Journal:  Lancet       Date:  2003-03-01       Impact factor: 79.321

6.  Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage.

Authors:  S van den Hof; G A Berbers; H E de Melker; M A Conyn-van Spaendonck
Journal:  Vaccine       Date:  1999-12-10       Impact factor: 3.641

7.  SLAM (CDw150) is a cellular receptor for measles virus.

Authors:  H Tatsuo; N Ono; K Tanaka; Y Yanagi
Journal:  Nature       Date:  2000-08-24       Impact factor: 49.962

8.  Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.

Authors:  K J Stittelaar; L S Wyatt; R L de Swart; H W Vos; J Groen; G van Amerongen; R S van Binnendijk; S Rozenblatt; B Moss; A D Osterhaus
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

9.  Measles virus protein-specific IgM, IgA, and IgG subclass responses during the acute and convalescent phase of infection.

Authors:  H S El Mubarak; S A Ibrahim; H W Vos; M M Mukhtar; O A Mustafa; T F Wild; A D M E Osterhaus; R L de Swart
Journal:  J Med Virol       Date:  2004-02       Impact factor: 2.327

Review 10.  The challenge of improving the efficacy of measles vaccine.

Authors:  May-Lill Garly; Peter Aaby
Journal:  Acta Trop       Date:  2003-01       Impact factor: 3.112

View more
  34 in total

1.  Inactivated Recombinant Rabies Viruses Displaying Canine Distemper Virus Glycoproteins Induce Protective Immunity against Both Pathogens.

Authors:  Renata da Fontoura Budaszewski; Andrew Hudacek; Bevan Sawatsky; Beate Krämer; Xiangping Yin; Matthias J Schnell; Veronika von Messling
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

2.  Recombinant nipah virus vaccines protect pigs against challenge.

Authors:  Hana M Weingartl; Yohannes Berhane; Jeff L Caswell; Sheena Loosmore; Jean-Christophe Audonnet; James A Roth; Markus Czub
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

3.  Mutational Analysis of Measles Virus Suggests Constraints on Antigenic Variation of the Glycoproteins.

Authors:  Benjamin O Fulton; David Sachs; Shannon M Beaty; Sohui T Won; Benhur Lee; Peter Palese; Nicholas S Heaton
Journal:  Cell Rep       Date:  2015-05-21       Impact factor: 9.423

Review 4.  Measles, the need for a paradigm shift.

Authors:  Emilie Javelle; Philippe Colson; Philippe Parola; Didier Raoult
Journal:  Eur J Epidemiol       Date:  2019-10-17       Impact factor: 8.082

5.  Association of persistent wild-type measles virus RNA with long-term humoral immunity in rhesus macaques.

Authors:  Ashley N Nelson; Wen-Hsuan W Lin; Rupak Shivakoti; Nicole E Putnam; Lisa Mangus; Robert J Adams; Debra Hauer; Victoria K Baxter; Diane E Griffin
Journal:  JCI Insight       Date:  2020-02-13

6.  Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques.

Authors:  Chien-Hsiung Pan; Nitya Nair; Robert J Adams; M Christine Zink; Eun-Young Lee; Fernando P Polack; Manmohan Singh; Derek T O'Hagan; Diane E Griffin
Journal:  Clin Vaccine Immunol       Date:  2008-02-20

7.  Comparison of the immune responses induced by chimeric alphavirus-vectored and formalin-inactivated alum-precipitated measles vaccines in mice.

Authors:  M Jeff Bergen; Chien-Hsiung Pan; Catherine E Greer; Harold S Legg; John M Polo; Diane E Griffin
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

8.  The receptor-binding site of the measles virus hemagglutinin protein itself constitutes a conserved neutralizing epitope.

Authors:  Maino Tahara; Shinji Ohno; Kouji Sakai; Yuri Ito; Hideo Fukuhara; Katsuhiro Komase; Melinda A Brindley; Paul A Rota; Richard K Plemper; Katsumi Maenaka; Makoto Takeda
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

9.  Crystal structure of measles virus hemagglutinin provides insight into effective vaccines.

Authors:  Takao Hashiguchi; Mizuho Kajikawa; Nobuo Maita; Makoto Takeda; Kimiko Kuroki; Kaori Sasaki; Daisuke Kohda; Yusuke Yanagi; Katsumi Maenaka
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

10.  Carrier Cells for Delivery of Oncolytic Measles Virus into Tumors: Determinants of Efficient Loading.

Authors:  Chun Xu; Mao Xia; Gang Meng; Chunyan Li; Aiqin Jiang; Jiwu Wei
Journal:  Virol Sin       Date:  2018-05-16       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.